Table 3.
Comparison between the obesity and metabolic syndrome subgroups across circulating biomarkers.
| Biomarkers | MHNW (N = 801) |
MHO (N = 157) |
MUNW (N = 26) |
MUO (N = 79) |
P-value1 |
|---|---|---|---|---|---|
| Leptin | 9.66 ± 6.66b | 22.14 ± 11.53c | 11.47 ± 7.37 | 19.76 ± 8.33 | <0.001 |
| Adiponectin | 2.58 ± 2.64ab | 1.57 ± 2.46c | 0.83 ± 0.71 | 0.87 ± 0.60 | <0.001 |
| Fasting glucose | 4.86 ± 0.62ab | 5.04 ± 0.74c | 6.33 ± 1.85 | 6.15 ± 1.98 | <0.001 |
| Triglyceride | 1.06 ± 0.84ab | 1.72 ± 2.62c | 2.43 ± 1.32 | 3.07 ± 3.22 | <0.001 |
| Total cholesterol | 4.65 ± 0.87b | 4.81 ± 0.94c | 4.63 ± 0.86 | 4.94 ± 0.98 | 0.006 |
| High-density lipoprotein | 1.49 ± 0.30ab | 1.34 ± 0.24c | 1.08 ± 0.32 | 1.17 ± 0.25 | <0.001 |
| Low-density lipoprotein | 2.79 ± 2.28 | 2.99 ± 0.76 | 3.01 ± 0.75 | 3.11 ± 0.75 | 0.433 |
1: P values were assessed by ANOVA or chi-squared test as statistically appropriate.
a: significantly different from MUNW group; b: significantly different from MUO group; c: significantly different from MUO group.